Print

Encore Pharmaceuticals, Inc. Receives Phase 2 SBIR Award 
10/19/2005 5:09:07 PM

RIVERSIDE, Calif.--(BUSINESS WIRE)--Aug. 9, 2005--Encore Pharmaceuticals Inc. (EncorePharma) announced today that it is the recipient of a Phase 2 Small Business Innovation Research (SBIR) award from the National Institute on Aging (NIH-NIA) in the field of neuroinflammation. The $750,000 grant award will support continued collaborative research and development between EncorePharma researchers Dr. Elaine Benaksas Schwartz, principal investigator, and Drs. Kenneth Hensley and Robert Floyd, researchers at the Oklahoma Medical Research Foundation (OMRF) in Oklahoma City.
//-->